Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
17.60
+0.58 (3.41%)
Jun 6, 2025, 4:00 PM - Market closed
Castle Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Net Income | -5.07 | 18.25 | -57.47 | -67.14 | -31.29 | -10.28 | Upgrade
|
Depreciation & Amortization | 42.42 | 16 | 12.33 | 10.54 | 3.41 | 0.47 | Upgrade
|
Other Amortization | - | - | - | - | - | 0.84 | Upgrade
|
Loss (Gain) From Sale of Investments | -5.55 | -7.24 | -5.49 | -1.37 | - | - | Upgrade
|
Stock-Based Compensation | 48.82 | 50.32 | 51.22 | 36.32 | 21.74 | 8.31 | Upgrade
|
Other Operating Activities | 0.75 | 1.67 | 0.41 | -20.01 | -8.74 | 1.38 | Upgrade
|
Change in Accounts Receivable | -13.6 | -12.64 | -14.93 | -6.22 | -4.63 | 1.66 | Upgrade
|
Change in Inventory | 0.8 | -0.19 | -3.96 | -1.68 | 0.33 | -0.98 | Upgrade
|
Change in Accounts Payable | -3.34 | -4.37 | 5.71 | 0.58 | -0.18 | 0.17 | Upgrade
|
Change in Other Net Operating Assets | 0.43 | 3.08 | 6.56 | 7.31 | 0.38 | 8.3 | Upgrade
|
Operating Cash Flow | 65.67 | 64.87 | -5.63 | -41.66 | -18.98 | 9.87 | Upgrade
|
Operating Cash Flow Growth | 405.97% | - | - | - | - | 40.63% | Upgrade
|
Capital Expenditures | -23.91 | -28.33 | -13.62 | -5.63 | -3.48 | -4.75 | Upgrade
|
Sale of Property, Plant & Equipment | 0.02 | 0.02 | 0.01 | 0.2 | 0.01 | 0 | Upgrade
|
Cash Acquisitions | - | - | - | -26.42 | -63.18 | - | Upgrade
|
Investment in Securities | -28.98 | -21.83 | -2.58 | -134.69 | - | - | Upgrade
|
Investing Cash Flow | -52.87 | -50.14 | -16.18 | -166.55 | -66.66 | -4.75 | Upgrade
|
Long-Term Debt Issued | - | 10 | - | - | - | - | Upgrade
|
Total Debt Issued | - | 10 | - | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -0.1 | -0.14 | -0.12 | -0.01 | -27.36 | Upgrade
|
Total Debt Repaid | -0.09 | -0.1 | -0.14 | -0.12 | -0.01 | -27.36 | Upgrade
|
Net Debt Issued (Repaid) | -0.09 | 9.9 | -0.14 | -0.12 | -0.01 | -27.36 | Upgrade
|
Issuance of Common Stock | 4.83 | 5 | 2.98 | 3.33 | 6.55 | 333.25 | Upgrade
|
Repurchase of Common Stock | -10.8 | -8.76 | -5.13 | -1.69 | -0.78 | - | Upgrade
|
Other Financing Activities | - | - | - | - | -0.34 | - | Upgrade
|
Financing Cash Flow | -6.06 | 6.14 | -2.3 | 1.52 | 5.42 | 305.89 | Upgrade
|
Net Cash Flow | 6.74 | 20.87 | -24.11 | -206.69 | -80.22 | 311.01 | Upgrade
|
Free Cash Flow | 41.75 | 36.54 | -19.25 | -47.29 | -22.47 | 5.11 | Upgrade
|
Free Cash Flow Growth | - | - | - | - | - | -15.86% | Upgrade
|
Free Cash Flow Margin | 12.03% | 11.00% | -8.76% | -34.51% | -23.88% | 8.16% | Upgrade
|
Free Cash Flow Per Share | 1.49 | 1.25 | -0.72 | -1.81 | -0.89 | 0.27 | Upgrade
|
Cash Interest Paid | 0.43 | 0.43 | 0.01 | 0.02 | 0 | 1.98 | Upgrade
|
Cash Income Tax Paid | 2.5 | 2.5 | 0.2 | 0.12 | 0.02 | 0.1 | Upgrade
|
Levered Free Cash Flow | 44.64 | 29.45 | 0.82 | -14.69 | -5.03 | 7.47 | Upgrade
|
Unlevered Free Cash Flow | 45 | 29.81 | 0.83 | -14.68 | -5.03 | 8.28 | Upgrade
|
Change in Net Working Capital | 13.71 | 13.6 | 6.62 | -1.05 | 1.64 | -9.51 | Upgrade
|
Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.